<DOC>
	<DOCNO>NCT01590498</DOCNO>
	<brief_summary>The purpose study determine whether radiotherapy improve cancer control overall survival among patient Castration resistant prostate cancer .</brief_summary>
	<brief_title>Radiotherapy v Observation CRPC</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>1 . Eligible patient histologically cytologically confirm adenocarcinoma prostate clinical radiologic evidence disease progression hormonal therapy 2 . Patients receive primary androgenablation therapy maintenance therapy . At least four week elapse withdrawal antiandrogens ( six week case bicalutamide ) enroll ment , avoid possibility confound result response antiandrogen withdrawal . 3 . Another requirement disease progression , indicate increase serum level PSA three consecutive measurement obtain least one week apart find physical examination image study . 4 . Normal cardiac function require . 1. patient Karnofsky performancestatus score 60 percent 2. prior treatment cytotoxic agent radioisotopes 3. history another cancer within precede five year , brain leptomeningeal metastasis , symptomatic peripheral neuropathy grade 2 high , serious medical condition .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Adenocarcinoma</keyword>
	<keyword>Prostatic Neoplasms</keyword>
	<keyword>Carcinoma</keyword>
	<keyword>Prostatic Diseases</keyword>
</DOC>